12th Annual NC Research Triangle Pulmonary Hypertension Symposium

November 13, 2020

Learning Objectives

Describe classification of Pulmonary Hypertension, according to the World Symposium classifications and including updates from the 6th World Symposium as well as the treatment options with respect to PAH-specific therapies

Recognize and distinguish similar disease processes that may or may not respond to Pulmonary Arterial Hypertensions specific therapy

Understand diagnostics used in the evaluation of pulmonary hypertension, including echocardiography, CT scan, VQ scan, and right heart catherterization hemodynamic profiles

Identify various PH subtypes and understand their diagnosis and clinical course, particularly chronic thromboembolic pulmonary hypertension and pulmonary hypertension associated with lung disease

Identify the role of clinical trials in the development of new PAH therapies, with a particular appreciation of the patient perspective as a clinical trial subject

Course summary
Available credit: 
  • 4.00 ACPE - Pharmacist
  • 4.00 AMA PRA Category 1 Credit(s)
  • 4.00 ANCC
  • 4.00 Attendance
  • 4.00 JA Credit - AH
    • 4.00 Approved for AMA PRA Category 1 Credit(s)
Registration Opens: 
11/13/2020
Registration Expires: 
11/12/2021
Activity Starts: 
11/13/2020 - 12:00pm
Activity Ends: 
11/13/2020 - 4:30pm
Rating: 
0

Available Credit

  • 4.00 ACPE - Pharmacist
  • 4.00 AMA PRA Category 1 Credit(s)
  • 4.00 ANCC
  • 4.00 Attendance
  • 4.00 JA Credit - AH
    • 4.00 Approved for AMA PRA Category 1 Credit(s)
Please login or register to take this course.